AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 294: E61-E68, 2008. First published October 30, 2007; doi:10.1152/ajpendo.00358.2007
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/E61    most recent
00358.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harada, N.
Right arrow Articles by Inagaki, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harada, N.
Right arrow Articles by Inagaki, N.

A novel GIP receptor splice variant influences GIP sensitivity of pancreatic β-cells in obese mice

Norio Harada,1 Yuichiro Yamada,1 Katsushi Tsukiyama,1 Chizumi Yamada,1 Yasuhiko Nakamura,1 Eri Mukai,1,2 Akihiro Hamasaki,1 Xibao Liu,1 Kentaro Toyoda,1 Yutaka Seino,1,3 and Nobuya Inagaki1,4

1Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, Kyoto; 2Japan Association for the Advancement of Medical Equipment, Tokyo; 3Kansai Electric Power Hospital, Osaka; and 4Core Research for Evolutional Science and Technology of Japan Science and Technology, Kyoto, Japan

Submitted 11 June 2007 ; accepted in final form 11 October 2007

Gastric inhibitory polypeptide (GIP) is an incretin that potentiates insulin secretion from pancreatic β-cells by binding to GIP receptor (GIPR) and subsequently increasing the level of intracellular adenosine 3',5'-cyclic monophosphate (cAMP). We have identified a novel GIPR splice variant in mouse β-cells that retains intron 8, resulting in a COOH-terminal truncated form (truncated GIPR). This isoform was coexpressed with full-length GIPR (wild-type GIPR) in normal GIPR-expressing tissues. In an experiment using cells transfected with both GIPRs, truncated GIPR did not lead to cAMP production induced by GIP but inhibited GIP-induced cAMP production through wild-type GIPR (n = 3–4, P < 0.05). Wild-type GIPR was normally located on the cell surface, but its expression was decreased in the presence of truncated GIPR, suggesting a dominant negative effect of truncated GIPR against wild-type GIPR. The functional relevance of truncated GIPR in vivo was investigated. In high-fat diet-fed obese mice (HFD mice), blood glucose levels were maintained by compensatory increased insulin secretion (n = 8, P < 0.05), and cAMP production (n = 6, P < 0.01) and insulin secretion (n = 10, P < 0.05) induced by GIP were significantly increased in isolated islets, suggesting hypersensitivity of the GIPR. Total GIPR mRNA expression was not increased in the islets of HFD mice, but the expression ratio of truncated GIPR to total GIPR was reduced by 32% compared with that of control mice (n = 6, P < 0.05). These results indicate that a relative reduction of truncated GIPR expression may be involved in hypersensitivity of GIPR and hyperinsulinemia in diet-induced obese mice.

gastric inhibitory polypeptide; gastric inhibitory polypeptide receptor; alternative splicing; dominant negative effect; obesity



Address for reprint requests and other correspondence: Y. Yamada, Dept. of Internal Medicine, Div. of Endocrinology, Diabetes, and Geriatric Medicine, Akita University School of Medicine, 1-1-1, Hondo, Akita 010-8543, Japan (e-mail: yamada{at}gipc.akita-u.ac.jp)




This article has been cited by other articles:


Home page
FASEB J.Home page
Y. Sztainberg, Y. Kuperman, O. Issler, S. Gil, J. Vaughan, J. Rivier, W. Vale, and A. Chen
A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease
FASEB J, July 1, 2009; 23(7): 2186 - 2196.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.